Podcast: Play in new window | Download (Duration: 15:10 — 14.0MB)
Subscribe: Apple Podcasts | Email | TuneIn | RSS
Post By: Adam Turteltaub
While the pandemic put many things on hold, it did not do the same for the False Claims Act (FCA). To find out what is happening in FCA activity we spoke with Patrick Hooper, Jordan Kearney and Alicia Macklin, partners at the law firm Hooper, Lundy & Bookman, PC and authors of the chapter Cutting Edge Topics in the FCA for the new HCCA book False Claims In Healthcare.
In this podcast they share that the opioid pandemic will still receive enforcement focus, particularly in areas such as treatment fraud. That’s likely to happen because of the increased number of people receiving medical coverage and the resurgence of the opioid epidemic during the pandemic.
They point to recent press releases and public comments by the FDA. The government also signaled it is looking at fraud related to electronic health records, which oven overlaps with opioid-related fraud.
We also discuss the now confusing area of subregulatory guidance. With the US Supreme Court decision in Azar v. Allina Health Services requiring more formal processes, and with a subsequent decision regarding local coverage decisions, many are wondering what to do.
Listen in to learn what to consider as you navigate these thorny, cutting edge FCA issues. And be sure to check out False Claims in Healthcare.